Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections

Research output: Patent

Abstract

The present invention relates to compositions comprising Cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and/or daptomycin or pharmaceutically acceptable salts thereof. The compositions show a synergistic effect in the inhibition of growth of Gram-positive bacteria. Thus, the compositions according to the invention may e.g. find use as medicaments in the treatment of Gram-positive bacterial infections.
Translated title of the contributionBacitracin og/eller daptomycin kombineret med cannabidiol til behandling af bakterielle infektioner
Original languageEnglish
IPCA61K 31/352,A61K 45/06,A61K 38/12,A61P 31/04
Patent numberWO 2108/234301 A1
Filing date27/12/2018
CountryDenmark
Priority date19/06/2017
Priority numberEP20170176612
Publication statusPublished - 27. Dec 2018

Fingerprint Dive into the research topics of 'Bacitracin and/or daptomycin combined with cannabidiol for treatment of bacterial infections'. Together they form a unique fingerprint.

Cite this